Advanced glycation end products (AGEs) is involved in the onset and exacerbation of Alzheimer’s disease while numerous studies favored that glycation help extracellular β-amyloid deposition as neuritic plaques and intracellular accumulation of hyperphosphorylated tau as neurofibrillary tangles [35,36]. The gene discussed is MAPT; the disease is Alzheimer disease.